Evidence map›Paper›PMID 36518447›Full record

ArticleToxicology reports2022

O Cebadero-Domínguez, B Ferrández-Gómez, S Sánchez-Ballester, J Moreno, A Jos, A M Cameán

Open access · goldAbstract read
In one paragraph

Article in Toxicology reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. [Research progress of electroactivity graphene-based materials in bone repair].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

O Cebadero-DomínguezArea of Toxicology. Faculty of Pharmacy. Universidad de Sevilla, Profesor García González Nº2, Sevilla, Spain.
B Ferrández-GómezPackaging, Transport and Logistic Research Institute, Albert Einstein 1, Paterna, 46980 Valencia, Spain.
S Sánchez-BallesterPackaging, Transport and Logistic Research Institute, Albert Einstein 1, Paterna, 46980 Valencia, Spain.
J MorenoArea of Cellular Biology, Faculty of Biology, Universidad de Sevilla, Avda, Reina Mercedes s/n, Sevilla, Spain.
A JosArea of Toxicology. Faculty of Pharmacy. Universidad de Sevilla, Profesor García González Nº2, Sevilla, Spain.
A M CameánArea of Toxicology. Faculty of Pharmacy. Universidad de Sevilla, Profesor García González Nº2, Sevilla, Spain.
Universidad de Sevilla · ESInstituto Tecnologico Del Embalaje, Transporte Y Logistica · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Graphene derivatives are expected to have a great impact in a wide range of applications, among them as food packaging materials. This is one of the sources of potential human oral exposure to them. However, studies devoted to investigating their putative toxic effects at the intestinal level are underrepresented in the scientific literature. Thus, this study aimed to investigate the in vitro toxicity of reduced graphene oxide (rGO) and graphene oxide (GO) in the human intestinal Caco-2 cell line. rGO and GO were firstly characterized and later, cell viability was assessed after exposure to 0-250 µg/mL rGO/GO for 24 and 48 h. Internalization was evidenced for both materials using transmission electron microscopy. A mean effective concentration (24 h) of 176.3 ± 7.6 µg/mL for cytotoxicity was obtained for rGO, whereas GO did not induce any change at the concentration range evaluated. However, both of them altered oxidative stress biomarkers, causing increased reactive oxygen species (ROS) and depletion of the glutathione content (GSH) after exposures up to 24 h. Further studies, particularly with rGO, are required to elucidate their toxicity profile in experimental models relevant for oral exposures.

Indexed as

Caco-2 cellsGraphene oxidein vitroReduced graphene oxideToxicity

Identifiers

PMID36518447
PMCPMC9742864
OpenAlexW4280593147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.